At Alexion, we are dedicated to making a meaningful impact for people living with rare diseases; our goal is to transform their reality for the better.
We recognize the important role that Externally Sponsored Research (ESR) can play in complementing our company sponsored research to expand medical and scientific knowledge on rare diseases and our medicines.
ESR is defined as a study with scientific and medical merit that is initiated and managed by an external investigator (‘sponsor’).
The external sponsor assumes the legal and regulatory responsibility for the conduct and management of the research as defined by applicable local laws and regulations.
Investigator Sponsored Research (ISR): an unsolicited research proposal from an external investigator, conducted independently of Alexion.
Externally Sponsored Collaborations (ESC): may either be solicited by Alexion or proposed by an external investigator. The investigator and Alexion can collaborate on the study design and interpretation of the results.
Please download this guide to review the requirements that must be met for Alexion to support any ESR proposal, the ESR submission process, and to highlight your obligations as the study sponsor.
We welcome unsolicited research proposals from qualified investigators in our strategic research areas of interest for each of our therapeutic areas.
ESR submissions are managed by Alexion directly in some countries, and by our parent company AstraZeneca in others.
Please submit your proposal below if you are based in one of the following countries, or your proposal relates to selumetinib or neurofibromatosis:
Australia, Austria, Belgium, Brazil, Canada, Denmark, Finland, France, Germany, Ireland, Italy, Japan, Luxembourg, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States.
For all other countries, please submit your proposal at Astrazeneca ESR Submission.
Veeva ID: GL/ALL/0064
